Replay available

Agios Pharmaceuticals, Inc. (AGIO) Q2 2025 Earnings Call

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) Q2 2025 earnings conference call, held 2025-07-31. Replay captured from the company's public earnings webcast.

Thu, July 31, 2025 at 8:00 AMendedReplay
Agios Pharmaceuticals, Inc. (AGIO) Q2 2025 Earnings Call

Hosted by

Featured presenters

Morgan Sanford

Vice President, Investor Relations

Brian Goff

Chief Executive Officer

Cecilia Jones

Chief Financial Officer

Sveta Milanova

Chief Commercial Officer

Dr. Sarah Hewens

Chief Medical Officer and Head of Research & Development

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Agios Pharmaceuticals, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:04.940 Good morning and welcome to AGO's second quarter 2025 conference call. 00:00:04.940 -- 00:00:07.900 At this time all participants are in a listen-only mode. 00:00:07.900 -- 00:00:10.740 There will be a question and answer session at the end. 00:00:10.740 -- 00:00:15.020 Please be advised that this call is being recorded at AGO's request. 00:00:15.020 -- 00:00:17.660 I would now like to turn the call over to AGO. 00:00:17.660 -- 00:00:20.100 Please go ahead. 00:00:22.620 -- 00:00:24.780 Thank you, operator. Good morning, everyone. 00:00:24.780 -- 00:00:29.160 I'm Morgan Sanford, vice president of Investor at AGO. 00:00:29.160 -- 00:00:34.600 Thank you for joining us to discuss AGO's pharmaceuticals second quarter 2025 financial 00:00:34.600 -- 00:00:38.940 results and business highlights. You can access the slides for today's call by going 00:00:38.940 -- 00:00:42.900 to the investor section of our website, AGO.com. 00:00:42.900 -- 00:00:47.740 Please move to the next slide. Today we'll be making certain forward-looking statements. 00:00:47.740 -- 00:00:52.240 Actual events and results could differ materially from those expressed or implied by 00:00:52.240 -- 00:00:58.060 any forward-looking statements. Because of various risks, uncertainties, and other factors, 00:00:58.060 -- 00:01:02.500 including those set forth in our most recent filings with the SEC and any other future 00:01:02.500 -- 00:01:07.280 filings that we may make with the SEC. Next slide, please. 00:01:07.280 -- 00:01:12.420 On the call with me today from AGO are Brian Goff, chief executive officer, Cecilia 00:01:12.420 -- 00:01:17.480 Jones, chief financial officer, Sveta Milanova, chief commercial officer, 00:01:17.480 -- 00:01:22.560 and Dr. Sarah Hewens, chief me...